231 related articles for article (PubMed ID: 25966978)
21. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells.
Namkoong S; Lee SJ; Kim CK; Kim YM; Chung HT; Lee H; Han JA; Ha KS; Kwon YG; Kim YM
Exp Mol Med; 2005 Dec; 37(6):588-600. PubMed ID: 16391520
[TBL] [Abstract][Full Text] [Related]
22. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1).
Fang Y; Olah ME
J Pharmacol Exp Ther; 2007 Sep; 322(3):1189-200. PubMed ID: 17565009
[TBL] [Abstract][Full Text] [Related]
23. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells.
Wang Y; Yan W; Lu X; Qian C; Zhang J; Li P; Shi L; Zhao P; Fu Z; Pu P; Kang C; Jiang T; Liu N; You Y
Eur J Cell Biol; 2011 Aug; 90(8):642-8. PubMed ID: 21616556
[TBL] [Abstract][Full Text] [Related]
25. A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway.
Xu L; Wang S; Li B; Sun A; Zou Y; Ge J
J Cell Mol Med; 2015 Jan; 19(1):92-102. PubMed ID: 25388834
[TBL] [Abstract][Full Text] [Related]
26. Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways.
Erdogdu O; Eriksson L; Xu H; Sjöholm A; Zhang Q; Nyström T
J Mol Endocrinol; 2013 Apr; 50(2):229-41. PubMed ID: 23343509
[TBL] [Abstract][Full Text] [Related]
27. TSH inhibits eNOS expression in HMEC-1 cells through the TSHR/PI3K/AKT signaling pathway.
Chen J; Shi M; Wang N; Yi P; Sun L; Meng Q
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):273-279. PubMed ID: 31606200
[TBL] [Abstract][Full Text] [Related]
28. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.
Takagi H; King GL; Robinson GS; Ferrara N; Aiello LP
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2165-76. PubMed ID: 8843903
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor receptor-2 activates ADP-ribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.
Daher Z; Boulay PL; Desjardins F; Gratton JP; Claing A
J Biol Chem; 2010 Aug; 285(32):24591-9. PubMed ID: 20529868
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
Grummer MA; Sullivan JA; Magness RR; Bird IM
Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
[TBL] [Abstract][Full Text] [Related]
31. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells.
Chung BH; Kim JD; Kim CK; Kim JH; Won MH; Lee HS; Dong MS; Ha KS; Kwon YG; Kim YM
Biochem Biophys Res Commun; 2008 Nov; 376(2):404-8. PubMed ID: 18789310
[TBL] [Abstract][Full Text] [Related]
32. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells.
Park JS; Hong GR; Baek SW; Shin DG; Kim YJ; Shim BS
J Korean Med Sci; 2002 Apr; 17(2):161-7. PubMed ID: 11961297
[TBL] [Abstract][Full Text] [Related]
33. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH; Zhao K
Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
[TBL] [Abstract][Full Text] [Related]
34. The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion.
Chin A; Svejda B; Gustafsson BI; Granlund AB; Sandvik AK; Timberlake A; Sumpio B; Pfragner R; Modlin IM; Kidd M
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G397-405. PubMed ID: 22038827
[TBL] [Abstract][Full Text] [Related]
35. Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2015 Sep; 6(29):27478-89. PubMed ID: 26317647
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes.
Bitar MS; Al-Mulla F
Dis Model Mech; 2015 Jan; 8(1):65-80. PubMed ID: 25381014
[TBL] [Abstract][Full Text] [Related]
37. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
[TBL] [Abstract][Full Text] [Related]
38. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Hashimoto A; Miyakoda G; Hirose Y; Mori T
Atherosclerosis; 2006 Dec; 189(2):350-7. PubMed ID: 16545819
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells.
Mahadev K; Wu X; Donnelly S; Ouedraogo R; Eckhart AD; Goldstein BJ
Cardiovasc Res; 2008 May; 78(2):376-84. PubMed ID: 18267956
[TBL] [Abstract][Full Text] [Related]
40. Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies.
Acurio J; Troncoso F; Bertoglia P; Salomon C; Aguayo C; Sobrevia L; Escudero C
Biomed Res Int; 2014; 2014():274507. PubMed ID: 24877077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
